J.-A. van Burik

1.3k total citations · 1 hit paper
7 papers, 942 citations indexed

About

J.-A. van Burik is a scholar working on Epidemiology, Infectious Diseases and Oncology. According to data from OpenAlex, J.-A. van Burik has authored 7 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 3 papers in Infectious Diseases and 2 papers in Oncology. Recurrent topics in J.-A. van Burik's work include Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). J.-A. van Burik is often cited by papers focused on Antifungal resistance and susceptibility (3 papers), Fungal Infections and Studies (2 papers) and Hematopoietic Stem Cell Transplantation (2 papers). J.-A. van Burik collaborates with scholars based in United States. J.-A. van Burik's co-authors include Raleigh A. Bowden, Anna Wald, Wendy M. Leisenring, Eric Sandler, Marc Gurwith, Carole B. Miller, Richard D. Mamelok, John R. Wingard, Jin Lin and Aileen McCabe and has published in prestigious journals such as New England Journal of Medicine, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

J.-A. van Burik

7 papers receiving 914 citations

Hit Papers

Epidemiology ofAspergillusInfections in a Large Cohort of... 1997 2026 2006 2016 1997 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.-A. van Burik United States 6 767 701 227 125 93 7 942
Morena Caira Italy 21 528 0.7× 590 0.8× 515 2.3× 100 0.8× 96 1.0× 49 1.3k
S. Milliken United Kingdom 10 404 0.5× 348 0.5× 254 1.1× 77 0.6× 44 0.5× 15 652
M Buelli Italy 13 387 0.5× 339 0.5× 149 0.7× 81 0.6× 194 2.1× 19 718
Márcia Garnica Brazil 19 550 0.7× 529 0.8× 277 1.2× 74 0.6× 146 1.6× 40 942
Angelika Boehme Germany 5 525 0.7× 480 0.7× 152 0.7× 88 0.7× 33 0.4× 8 653
Julie M. Bryar United States 7 400 0.5× 436 0.6× 111 0.5× 39 0.3× 47 0.5× 9 544
Paola Cappellano Brazil 9 408 0.5× 408 0.6× 130 0.6× 52 0.4× 37 0.4× 16 557
Dimitrios P. Kontoyiannis United States 5 601 0.8× 566 0.8× 86 0.4× 120 1.0× 10 0.1× 6 744
R.I. Schiff United States 8 465 0.6× 524 0.7× 91 0.4× 29 0.2× 147 1.6× 19 888
Lars Tramsen Germany 18 383 0.5× 429 0.6× 207 0.9× 44 0.4× 94 1.0× 30 834

Countries citing papers authored by J.-A. van Burik

Since Specialization
Citations

This map shows the geographic impact of J.-A. van Burik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.-A. van Burik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.-A. van Burik more than expected).

Fields of papers citing papers by J.-A. van Burik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.-A. van Burik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.-A. van Burik. The network helps show where J.-A. van Burik may publish in the future.

Co-authorship network of co-authors of J.-A. van Burik

This figure shows the co-authorship network connecting the top 25 collaborators of J.-A. van Burik. A scholar is included among the top collaborators of J.-A. van Burik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.-A. van Burik. J.-A. van Burik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Park, Kyong Soo, Angelika C. Gruessner, D. E. R. Sutherland, et al.. (2007). Red cell aplasia and autoimmune hemolytic anemia following immunosuppression with alemtuzumab, mycophenolate, and daclizumab in pancreas transplant recipients. Haematologica. 92(8). 1029–1036. 44 indexed citations
2.
Burik, J.-A. van & Claudio G. Brunstein. (2007). Infectious complications following unrelated cord blood transplantation. Vox Sanguinis. 92(4). 289–296. 25 indexed citations
3.
Burik, J.-A. van, John R. Perfect, Arnold Louie, et al.. (2006). Efficacy of posaconazole (POS) vs standard therapy and safety of POS in hematopoietic stem cell transplant (HSCT) recipients vs other patients with aspergillosis. Biology of Blood and Marrow Transplantation. 12(2). 137–137. 1 indexed citations
4.
Berrey, M. Michelle & J.-A. van Burik. (2001). Symmetric Peripheral Gangrene. New England Journal of Medicine. 344(21). 1593–1593. 5 indexed citations
5.
White, Mary H., Raleigh A. Bowden, Eric Sandler, et al.. (1998). Randomized, Double‐Blind Clinical Trial of Amphotericin B Colloidal Dispersion vs. Amphotericin B in the Empirical Treatment of Fever and Neutropenia. Clinical Infectious Diseases. 27(2). 296–302. 212 indexed citations
6.
Wald, Anna, Wendy M. Leisenring, J.-A. van Burik, & Raleigh A. Bowden. (1997). Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation. The Journal of Infectious Diseases. 175(6). 1459–1466. 563 indexed citations breakdown →
7.
Bowden, Raleigh A., et al.. (1996). Phase I Study of Amphotericin B Colloidal Dispersion for the Treatment of Invasive Fungal Infections after Marrow Transplant. The Journal of Infectious Diseases. 173(5). 1208–1215. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026